Blog Archives

Transparency & Clinical Trials

This morning’s WSJ’s Science Journal takes a particularly harsh and somewhat uncharacteristic (at least for WSJ) look at the pharmaceutical industry’s practice of sequestering less than favorable clinical trials’ results.  Appears that the sheer volume of clinical trials today, 50K


Fortuitous or Planted Story on EmergingMed

Read in the WSJ this morning an interesting article on new approaches that are being taken to introduce/solicit consumers to participate in clinical trials. The problem seems to be that consumers actually have little reluctance to participate in such trials.


Who We Are

Chilmark Research is the only industry analyst firm focusing solely on health IT. We combine proven research methodologies with intelligence and insight to provide cogent analyses of the emerging technologies that have the greatest potential to improve healthcare. We do not shy away from making tough calls, and are respected in the industry for our direct and thoughtful commentary.